SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.58
arrow_upward
+1.66%(+0.026) 1D
$1.40
arrow_downward
-11.39% (-0.18)bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.59
High
$1.70
Low
$1.45
Mkt. cap
4.13M
Avg. vol.
661.67K
Volume
63.44K
52-wk high
$52.00
52-wk low
$1.15
EPS
-$22.40
Beta
2.27
Shares outstanding
164.40K
No. of employees
45
Open
$1.59
High
$1.70
Low
$1.45
Mkt. cap
4.13M
Avg. vol.
661.67K
Volume
63.44K
52-wk high
$52.00
52-wk low
$1.15
EPS
-$22.40
Beta
2.27
Shares outstanding
164.40K
No. of employees
45
News stories
From web sources and news partners
Stocktwits
·
43 minutes ago
Nasdaq 100 Ends Worst Week Since 2020, S&P 500 In Correction Territory As AI Rout Sours Sentiment — ANT, NVDA, TTWO, ZS, CRWD In Focus
The Motley Fool
·
1 hour ago
Report: Goldman Sachs Predicts the S&P 500 Will Gain 26% in 12 Months
Yahoo Finance
·
1 hour ago
The S&P 500 Has More Than Tripled in 10 Years, Even After Its Latest Pullback. Here’s What $1,000 in VOO Could Have Become.
FXStreet
·
5 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
FoundedJan 1, 2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitescinai.com